Study of INCB123667 in Subjects With Advanced Solid Tumors
Incyte Corporation
Incyte Corporation
TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)
Genmab
Henan Cancer Hospital
Hoffmann-La Roche
Japanese Foundation for Cancer Research
AstraZeneca
Eli Lilly and Company
Pfizer
Gustave Roussy, Cancer Campus, Grand Paris
Hoffmann-La Roche
AstraZeneca
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
The First Affiliated Hospital with Nanjing Medical University
University of California, Irvine
Jiangsu Hansoh Pharmaceutical Co., Ltd.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Japanese Foundation for Cancer Research
UNICANCER
Fudan University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Fudan University
Queen Mary University of London
MedSIR
Lebanese University
OHSU Knight Cancer Institute
University of California, Irvine
OHSU Knight Cancer Institute
University of Nebraska
Infinity Pharmaceuticals, Inc.
Eastern Cooperative Oncology Group
M.D. Anderson Cancer Center
Spanish Breast Cancer Research Group
Jiangsu HengRui Medicine Co., Ltd.
Rutgers, The State University of New Jersey
iOMEDICO AG
Hoffmann-La Roche
University of Alabama at Birmingham
National Cancer Institute (NCI)
Henan Cancer Hospital
Japan Breast Cancer Research Group
NSABP Foundation Inc
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Dana-Farber Cancer Institute
SCRI Development Innovations, LLC
Novartis
NSABP Foundation Inc
Massachusetts General Hospital